Le Lézard21m
INOVIO Announces Promising Interim Results from Ongoing Proof-of-Concept Clinical Trial of DNA-Encoded Monoclonal Antibodies (DMAbs) for COVID-19
DMAb levels remained stable for 72 weeks in all participants (n=24) who have reached that timepointNo anti-drug antibodies (ADA): no immune rejection of the DMAbs was detected across ~1,000 blood ...
Auganix12m
Path of Fury – Episode I: Tetsuo’s Tower Review – Kung Flow
A review of high-octane, kung-fu action VR title Path of Fury - Episode 1: Tetsuo’s Tower | VR Gaming Reviews from Auganix.org ...